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Abstract
We assessed the associations of prenatal diethylstilbestrol (DES) exposure, a potent estrogen, with sexual orientation and 
gender identity in 3306 women and 1848 men who participated in a study of prenatal DES exposure. Odds ratios (OR) and 
95% confidence intervals (CI) were derived from logistic regression models adjusted for birth year, study cohort, and educa-
tion. Among women, the OR for DES in relation to reporting sexual orientation identity as nonheterosexual was 0.61 (95% 
CI 0.40–0.92) primarily due to a strong inverse association with a lesbian identity (OR 0.44, 95% CI 0.25–0.76). Among 
men, the OR for DES in relation to reporting a nonheterosexual sexual orientation identity was 1.4 (95% CI 0.82–2.4), and 
ORs were similar for having a gay identity (1.4, 95% CI 0.72–2.85) and bisexual identity (1.4, 95% CI 0.57–3.5). Only five 
individuals reported a gender identity not conforming to that assigned at birth, preventing meaningful analysis. Women who 
were prenatally exposed to DES were less likely to have a lesbian or bisexual orientation, while DES-exposed men were 
somewhat more likely to report being gay or bisexual, but estimates were imprecise.
Keywords Diethylstilbestrol · Sexual orientation identity · Gender identity · In utero exposure
Introduction
Research on the biological foundations of sexual orientation, 
an enduring pattern of emotional, romantic, and/or sexual 
attractions to men, women, or both sexes (American Psy-
chological Association, 2019) supports roles for genetics, 
epigenetics, and prenatal hormonal exposure, in particu-
lar testosterone (Berenbaum & Beltz, 2016; Hines, 2011a, 
2020; Fisher, Ristori, Morelli, & Maggi, 2018). The origins 
of gender identity, a person’s concept of self as female, male, 
or other, may be more complex regarding the relative con-
tributions of social and biological influences and the role 
of early testosterone exposure (Berenbaum & Beltz, 2016; 
Hines, 2011b).
In general, experimental studies in animals show that high 
concentrations of testosterone at critical developmental peri-
ods increase male-typical neural and behavioral development 
while lower concentrations result in female-typical neural and 
behavioral development (reviewed in Hines, 2011a). Direct 
data in humans on sexual orientation are based on studies of 
rare conditions associated with an altered hormonal milieu 
in utero. Classical congenital adrenal hyperplasia (CAH) is 
an autosomal recessive disorder involving prenatal androgen 
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excess that can result in virilization of the external genitalia 
in females. Results of numerous studies of women with CAH 
show that these women are less likely to be exclusively or 
almost exclusively heterosexual compared with women who 
do not have CAH, and some of these studies show a positive 
association with severity of the disorder (Hines, 2011a). In 
contrast, most studies in men with CAH find little differ-
ence in sexual orientation (Gehrmann et al., 2019). Androgen 
insensitivity syndrome (AIS) is an intersex condition that 
results in partial or complete inability of the cell to respond 
to androgens. Of the few studies on complete AIS, when the 
external genitalia are female, most find that these individu-
als tend to have an androphilic sexual orientation (Hines, 
Ahmed, & Hughes, 2003; Wisniewski et al., 2000).
The use of diethylstilbestrol, a synthetic nonsteroidal 
estrogen, during pregnancy, provides another test of the 
influence of prenatal hormonal exposure on sexual orienta-
tion. Despite its lack of efficacy, high-dose exposure occurred 
when DES was administered to several million pregnant 
women in the U.S. and Europe from the early 1940s through 
the 1960s (Noller & Fish, 1974) for prevention of spontane-
ous abortion and premature delivery. With the demonstration 
in 1971 of a strong association between DES and clear cell 
adenocarcinoma of the vagina and cervix in young women 
(Herbst, Ulfelder, & Poskanzer, 1971), use in pregnancy was 
discontinued.
DES is a highly potent full agonist of the nuclear estrogen 
receptors, estrogen receptor (ER)α and ERβ (Jordan, 2013; 
Seiler, Autrup, & Autrup, 2012), and compared to estradiol, 
DES has greater affinity to ERs (Kuiper et al., 1997) and 
bioavailability when taken orally. DES can be metabolized 
in all species evaluated to produce either hormonally inactive 
or estrogenic compounds (Korach, Metzler, & McLachlan, 
1978), but metabolism in human pregnancy is unknown.
Prenatal exposure to DES from rodent studies shows 
increased estrogen, progesterone, and testosterone produc-
tion in females owing to enlargement of the ovary, though 
even with correction for ovarian size testosterone produc-
tion remains elevated in the exposed (Haney, Newbold, & 
McLachlan, 1984). In male rodents, relatively low-dose 
exposure does not affect steroidogenesis; however, higher 
doses of DES suppress testicular testosterone production as 
well as androgen receptor expression (Adamsson, Brokken, 
Paranko, & Toppari, 2008). While we do not know how DES 
was metabolized in human pregnancy, outcomes in animals 
exposed to DES during development have been extremely 
like those in comparably exposed humans (McLachlan, 
2016).
Based on the animal paradigm and human evidence indi-
cating that prenatal testosterone exposure influences male-
type development, DES could influence nonheterosexual ori-
entation in women by increasing testosterone production, a 
phenomenon that has been observed in female mice exposed 
in utero to DES (Haney et al., 1984). Alternatively, rapid 
metabolism of testosterone to estradiol in normal human 
pregnancy may protect the female fetus from androgen 
effects. In males, high doses of DES could affect nonhetero-
sexual orientation by decreasing testosterone production and/
or androgen receptor expression.
While a review of gender-related behavior in women 
exposed prenatally to DES compared with women who 
were unexposed concluded that there were no distinct dif-
ferences in gender-related behaviors between exposed and 
unexposed women (Newbold, 1993), there was some evi-
dence for greater prevalence of certain sexual characteris-
tics, including bisexuality or homosexuality. We previously 
reported that prenatally DES-exposed women were less likely 
than unexposed women to report same-sex partners (odds 
ratio [OR] = 0.71, 95% confidence interval [CI] 0.51–0.98), 
but prenatally DES-exposed men were slightly more likely 
to report same-sex partners than unexposed men (OR = 1.3, 
95% CI 0.80–2.1) (Titus-Ernstoff et al., 2003).
Research on sexual orientation and gender identity has 
markedly advanced since our initial report of usual sexual 
partners in adulthood based on data collected in 1994. 
Recently, we ascertained additional information in our cohort 
on sexual orientation identity, a person’s identity based on 
their attractions, related behaviors, and membership in a 
community of others who share those attractions and asked 
about gender identity for the first time to assess possible asso-
ciations with prenatal exposure to DES.
Method
Participants
The present study used data from a longitudinal cohort 
study. In 1994, the National Cancer Institute (NCI) com-
bined cohorts that were followed previously (1970s–1980s) 
and assembled new cohorts (comprising mothers or off-
spring of existing cohort members) to establish the US 
NCI DES combined cohort follow-up study. The resulting 
combined cohort study is comprised of prenatally exposed 
and unexposed women and men whose mothers attended 
a large, private infertility practice (Horne Cohort), or par-
ticipated in the Women’s Health Study of women who were 
and were not given DES during pregnancy (WHS Cohort; 
Greenberg et al., 1984), or enrolled in a clinical trial of DES 
(or placebo) use in pregnancy (Dieckmann Cohort; Bibbo 
et al., 1977). The women’s combined cohort additionally 
included prenatally DES-exposed and unexposed women 
who participated in the National Cooperative Diethylstil-
bestrol Adenosis Project ([DESAD] cohort; Labarthe et al., 
1978); in this cohort, the unexposed were either sisters of 
the exposed participants (24%) or women identified from 
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the same record review as the exposed (76%). The primary 
goal of the DESAD study was to provide annual clinical 
examinations for the daughters to ascertain their risk of 
vaginal and cervical abnormalities and follow the natural 
history of these conditions. Because of this, many more 
exposed than unexposed daughters were enrolled. The 
men’s combined cohort additionally included prenatally 
DES-exposed and unexposed men who participated in a 
study at the Mayo Clinic (Leary et al., 1984).
The NCI follow-up of the combined cohorts began in 
1994 with a mailed questionnaire, and subsequent question-
naires were mailed approximately every 5 years in 1997, 
2001, 2006, 2011, and 2016. Among the 6571 women (4474 
exposed, 2097 unexposed) approached for participation in 
1994, 88% of exposed and 84% of unexposed women com-
pleted the NCI combined cohort baseline questionnaire. In 
subsequent follow-up of the NCI combined cohort, partici-
pation percents in the exposed and unexposed women were 
94% and 94% for the 1997 questionnaire, 90% and 90% for 
the 2001 questionnaire, 82% and 85% for the 2006 question-
naire, 76% and 77% for the 2011 questionnaire, and 73% and 
74% for the 2016 questionnaire, respectively, for the exposed 
and unexposed.
Among the 3600 men (1710 exposed, 1890 unexposed) 
approached in 1994, 79% and 72% of exposed and unexposed 
men completed the NCI combined cohort baseline question-
naire. In subsequent follow-up of the NCI combined cohort, 
participation percents were 94% and 95% for the 1997 ques-
tionnaire, 88% and 86% for the 2001 questionnaire, 83% and 
83% for the 2006 questionnaire, 74% and 74% for the 2011 
questionnaire, and 75% and 73% for the 2016 questionnaire, 
respectively, for the exposed and unexposed men.
Eligibility for the current analysis required completion 
of the questions on sexual orientation identity and gender 
identity contained in the 2016 follow-up questionnaire. Over 
the course of the NCI combined cohort study, 6048 women 
had responded to at least one questionnaire and were consid-
ered study participants. One of the women’s subcohorts was 
not approached in 2016 (n = 1007), and an additional 222 
women had died since 1994. Of the remaining 4819 women 
(3223 exposed, 1596 unexposed), 3371 (2260 exposed, 1111 
unexposed) agreed to complete the full questionnaire. Of 
these, 3306 (2220 [98%] and 1086 [98%] of the exposed and 
unexposed, respectively) answered the relevant questions on 
sexual orientation identity and gender identity.
Over the course of the NCI combined cohort study, 2924 
men had responded to at least one questionnaire and were 
considered participants; 256 of these had died since 1994. Of 
the remaining 2668 (1322 exposed, 1346 unexposed) men, 
1885 (947 exposed, 938 unexposed) agreed to complete the 
full 2016 questionnaire. Of these, 1848 (933 [98.5%] exposed 
and 915 [97.5%] unexposed) answered the relevant questions 
on sexual orientation identity and gender identity.
Measures
The 1994 NCI combined cohort baseline questionnaire 
included a question on the sex of sexual partners in adult-
hood. In 2016, we included a question on sexual orientation 
identity (“Which of the following best represents how you 
think of yourself? Gay or lesbian; bisexual; straight, that 
is, not gay, lesbian or bisexual; other, please specify; prefer 
not to respond”) and a question on gender identity (“Which 
of the following best represents how you currently think of 
yourself? Woman; man; other, please specify; prefer not to 
respond”). When participants left the question blank, they 
were categorized with those who indicated they preferred not 
to respond. A variable for nonheterosexuality was created by 
combining responses for gay or lesbian, bisexual, and other. 
The overlap between those included in the 2016 question-
naire analysis and the 1994 analysis was about 65% for both 
women and men.
DES Exposure
For all combined cohort participants, prenatal exposure to 
DES, or lack thereof, was documented by the birth record or a 
physician’s note. Gestational week of first DES exposure was 
available for 72% of women and 74% of men. We classified 
the individual cohorts as high or low dose based on differ-
ences in prescribing practices by U.S. region. In women, the 
high-dose cohorts were from Boston (DESAD, WHS sub-
cohort, and Horne), Chicago (Dieckmann), and California 
(DESAD); low-dose cohorts were from Texas, Minnesota, 
and Wisconsin (DESAD). In men, the high-dose cohorts were 
from Boston (WHS subcohort, Horne) and Chicago (Dieck-
mann); the low-dose cohort was from Mayo Clinic. Dose 
and gestational age at first DES exposure were unavailable 
for WHS participants from New Hampshire and Maine, so 
exposure level could not be classified for those subcohorts 
(9% of exposed women and 19% of exposed men). Agree-
ment between the dose classification and individual doses 
was excellent among those with complete data (Palmer et al., 
2006). The presence or absence of vaginal epithelial changes 
(VEC), which are correlated with an earlier and higher DES 
dose in utero (Herbst, Poskanzer, Robby, Friedlander, & 
Scully 1975), was available for 99% of prenatally exposed 
women in the DESAD observational study and the Dieck-
mann clinical trial cohort but was not available in the other 
cohorts. Attained education (highest grade completed) was 
collected on the women’s and men’s 1994 questionnaire.
Data Analysis
Women and men were analyzed separately. To analyze 
the 2016 data, OR and 95% CI (used to assess statistical 
significance) are derived from logistic regression models 
450 Archives of Sexual Behavior (2020) 49:447–454
1 3
(Breslow & Day, 1980) with sexual orientation identity 
(nonheterosexual vs. heterosexual) as the dependent vari-
able, DES exposure as the independent variable, and birth 
year and cohort as covariates. We additionally included 
education as a covariate because we thought it might be 
associated with reporting of sexual orientation identity on 
the questionnaires. A polytomous logistic regression model 
was used to model a multinomial response (i.e., a multi-
level response whose levels have no inherent ordering) for 
sexual orientation identity (heterosexual; gay or lesbian; 
bisexual). In this model, the dependent or outcome vari-
able was dummy coded into multiple 1/0 variables except 
for one. The model estimated a separate binary logistic 
regression model for each of the dummy variables with 
each having its own intercept and regression coefficients 
(so the predictors can affect each category differently). The 
association of DES and sexual orientation identity could 
not be computed separately by cohort because of the small 
number of outcomes. Associations were evaluated by DES 
dose (high dose and low dose vs. unexposed as the refer-
ence group) and timing of first DES administration (< 8, 
8–14, 15 + weeks, missing vs. unexposed as the reference 
group), and in the Dieckmann and DESAD cohorts, by the 
presence or absence of VEC in the women (vs. unexposed 
as the reference group). Regression models for DES dose 
did not include cohort as a covariate because dose was 
based on cohort membership. The number of participants 
reporting a gender identity different from that assigned at 
birth was too small to analyze statistically. Finally, we com-
pared consistency of participants’ responses to the 2016 
question assessing sexual orientation identity with their 
previous responses to the 1994 question assessing usual 
sex partners in adulthood.
Results
The mean age of DES-exposed women was 62.1 years 
(median = 63.3, SD = 5.4) and of unexposed women was 
63.2 years (median = 64.2, SD = 6.3), while in the men the 
means were 62.9 years (median = 64.8, SD = 6.9) in the 
exposed and 63.4 years (median = 64.6, SD = 6.1) in the 
unexposed. Attained education was high overall and higher 
for the DES-exposed than for the unexposed women and men 
(Table 1). Study participants were predominantly Caucasian 
(98% and 97% of exposed and unexposed women and 93% 
and 92%, respectively, of men).
Few women (11 exposed [0.50%] and 6 unexposed 
[0.55%]) and men (14 exposed [1.5%] and 6 unexposed 
[0.66%]) who answered the questions on sexual orientation 
identity selected the “prefer not to respond” option. Over 
96% of respondents indicated that they were heterosexual. 
The distribution of sexual orientation and gender identity 
according to DES exposure status for women and men is 
shown in Table 2, along with ORs adjusted for birth year, 
education, and cohort. The OR for DES in relation to self-
report of being nonheterosexual (gay/lesbian, bisexual or 
other) was 0.61 (95% CI = 0.40–0.92) for women and 1.4 
(95% CI = 0.82–2.4) for men.
Table 1  Distribution (%) of 
demographic factors by DES 
exposure status in women and 
men
Women Men
DES exposed DES unexposed DES exposed DES unexposed
N = 2220 N = 1086 N = 933 N = 915
Birth year
  < 1952 36.0 42.6 52.6 47.8
 1952–1955 31.0 29.5 20.8 26.6
 1956 + 33.0 27.9 26.6 25.7
Cohort
 DESAD 76.3 43.7 – –
 Mayo – – 45.7 44.4
 Dieckmann 7.6 13.6 15.4 13.9
 Horne 6.9 9.3 19.6 11.5
 WHS 9.2 33.4 19.3 30.3
Education (from 1994 questionnaire)
 ≤ High school (HS) 12.0 16.8 14.7 18.9
 Some post-HS 21.2 23.2 18.9 22.1
 College 34.4 31.7 38.6 30.9
 Post-college 29.6 27.7 27.4 28.0
 Missing 2.8 0.66 0.43 0.11
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We assessed, compared with the unexposed, whether DES 
dose or gestational week at first DES exposure in the women 
and men, and VEC in the women were related to sexual ori-
entation identity (Table 3). Only women exposed to a low 
DES dose showed a reduced OR of reporting being nonhet-
erosexual compared with self-report of being heterosexual 
(0.33, 95% CI = 0.13–0.85), though this was based on a small 
number of women. In contrast, among men, the OR of report 
of being nonheterosexual compared with heterosexual for 
those exposed to a high DES dose almost reached statistical 
significance (1.8, 95% CI = 0.96–3.3). Among women, ORs 
appeared similar by gestational week at DES exposure. While 
Table 2  Odds ratio (OR) and 95% confidence intervals (CI) for prenatal DES exposure and sexual orientation identity
a Odds ratios (OR) are from either binary logistic regression (nonheterosexual vs. heterosexual (reference group) as the dependent variable and 
DES as an independent variable) or polytomous logistic regression models (gay or lesbian, bisexual vs. heterosexual (reference group) as the 
dependent variable and DES as an independent variable). Models also included birth year (continuous), education and cohort as independent 
variables
Women Men
Exposed Unexposed OR (95% CI)a Exposed Unexposed OR (95% CI)a
N = 2220 N = 1086 N = 933 N = 915
Sexual orientation identity
 Heterosexual 2142 (96.5) 1037 (95.5) 1.00 883 (94.6) 884 (96.6) 1.00
 Nonheterosexual 67 (3.0) 43 (4.0) 0.61 (0.40–0.92) 36 (3.9) 25 (2.7) 1.39 (0.82–2.37)
 Gay or Lesbian 30 (1.4) 28 (2.6) 0.44 (0.25–0.76) 21 (2.3) 15 (1.6) 1.44 (0.72–2.85)
 Bisexual 33 (1.5) 12 (1.1) 0.96 (0.48–1.92) 13 (1.4) 8 (0.87) 1.41 (0.57–3.49)
 Other 4 (0.18) 3 (0.28) 2 (0.21) 2 (0.22)
 Preferred not to respond 11 (0.50) 6 (0.55) 14 (1.5) 6 (0.66)
Gender identity
 Woman 2214 (99.7) 1085 (99.9) 1 (0.11) 0 (0.00)
 Man 1 (0.05) 0 (0.0) 930 (99.7) 910 (99.5)
 Other 1 (0.05) 0 (0.0) 1 (0.11) 1 (0.11)
 Preferred not to respond 4 (0.18) 1 (0.1) 1 (0.11) 4 (0.44)
Table 3  Odds ratio (OR) and 95% confidence intervals (CI) for prenatal DES exposure and sexual orientation identity by DES dose, timing of 
DES exposure, and presence or absence of vaginal epithelial changes (VEC)
a Analysis of dose excludes one of the WHS cohorts (Dartmouth)
b Analysis of gestational age at first exposure excludes WHS cohorts
c Analysis of VEC includes DESAD and Dieckmann cohorts only
Women Men
Hetero-
sexual
Non-
heterosexual
OR 95% CI Hetero-
sexual
Non-
heterosexual
OR 95% CI
DES  dosea
 Unexposed 1037 (96.0) 43 (4.0) 1.00 – 722 (96.9) 23 (3.1) 1.00 –
 Low dose 469 (99.0) 5 (1.0) 0.33 0.13–0.85 412 (98.1) 8 (1.9) 0.68 0.30–1.57
 High dose 1537 (96.2) 61 (3.8) 0.81 0.54–1.21 369 (93.9) 24 (6.1) 1.79 0.96–3.33
Gestational age at first  exposureb
 Unexposed 687 (95.4) 33 (4.6) 1.00 – 617 (97.3) 17 (2.7) 1.00 –
  <= 7 weeks 480 (96.2) 19 (3.8) 0.64 0.35–1.17 248 (94.7) 14 (5.3) 1.48 0.66–3.30
 8–14 weeks 678 (98.0) 14 (2.0) 0.44 0.23–0.84 256 (97.7) 6 (2.3) 0.98 0.37–2.61
 15 + weeks 394 (97.5) 10 (2.5) 0.63 0.30–1.32 149 (98.7) 2 (1.3) 0.55 0.12–2.49
VECc
 Unexposed 593 (95.8) 26 (4.2) 1.00 – – – – –
 Exposed, no VEC 851 (97.5) 22 (2.5) 0.55 0.30–0.99 – – – –
 Exposed, VEC 923 (96.3) 35 (3.7) 0.75 0.44–1.28 – – – –
452 Archives of Sexual Behavior (2020) 49:447–454
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the ORs varied by gestational week among the men, they 
were based on a small number of participants. ORs for DES 
exposure compared with no exposure in relation to nonhet-
erosexuality were 0.75 (95% CI = 0.44–1.3) in women with 
a history of VEC and 0.55 (95% CI = 0.30–0.99) in those 
without such a history.
We also examined associations of DES exposure sepa-
rately for lesbian/gay orientation and bisexual orientation. 
Sexual orientation identity reported as “other” was not 
examined as very few women (4 exposed and 3 unexposed) 
and men (2 exposed and 2 unexposed) reported it. Among 
women, DES exposure was inversely associated with report-
ing a gay/lesbian identity; OR 0.44 (95% CI 0.25–0.76) but 
was not associated with a bisexual identity (OR 0.96, 95% 
CI = 0.48–1.9) (Table 2). Among men, the ORs were ele-
vated for DES in relation to reporting a gay identity (OR 
1.4, 95% CI = 0.72–2.9) or bisexual identity (OR 1.4, 95% 
CI = 0.57–3.5), although confidence intervals were wide and 
included 1.0. The numbers of individuals in specific catego-
ries of sexual orientation identity were too small to evaluate 
possible associations with dose and timing of DES in women 
and men, or with the presence/absence of VEC in women.
Only two women, both DES exposed, and 3 men (2 
exposed and 1 unexposed) reported gender identity that did 
not conform with the sex they were assigned at birth. Five 
DES-exposed persons and five unexposed preferred not to 
answer the question on gender identity.
Finally, we assessed the concordance of sexual orientation 
identity reported on the 2016 questionnaire with the previous 
report of adult sexual partners on the 1994 questionnaire. Of 
2986 women who reported only opposite sex partners on the 
1994 questionnaire, 30 (1%) reported bisexual, gay/lesbian 
or other on the 2016 questionnaire. Among men, the cor-
responding percent was 15 (0.88%) of 1704. In addition, we 
recomputed the OR for DES in relation to same-sex partners 
in the subset who also responded to the sexual orientation 
identity question in 2016. In this subset, the OR for DES in 
relation to same-sex partners was 0.65 (0.43–0.97) in women 
and 1.3 (0.74–2.4) in men.
Discussion
The NCI combined cohorts of women and men represent one 
of the only human studies allowing evaluation of the influ-
ence of a potent synthetic estrogen on early fetal development 
in a population with documented DES exposure status. Brain 
organization that occurs in the prenatal period may influ-
ence an individual’s sexual and gender identities, with one 
hypothesis that variance in exposure to gonadal hormones 
may mediate this influence, along with genes and maternal 
factors (Fisher et al., 2018; Roselli, 2018), including maternal 
immune response (Bogaert et al., 2018).
We found that women exposed in utero to DES were sig-
nificantly less likely to report being gay/lesbian, but DES 
exposure was not associated with bisexuality. The association 
with gay/lesbian orientation was strongest for exposure to 
a low cumulative dose of DES. We observed no consistent 
patterns of association between timing of first gestational 
DES exposure and sexual orientation identity among exposed 
women. The current results agree with those from our earlier 
study (Titus-Ernstoff et al., 2003), which indicated that pre-
natally DES-exposed women were slightly more likely than 
unexposed women to have ever married and were less likely 
to report sexual partners of the same sex.
In contrast to the findings for women, DES-exposed men 
were more likely to report being gay or bisexual; however, 
this estimate was imprecise likely owing to the men’s cohort 
being smaller than the women’s cohort. The findings in men 
agree with our previous study of sexual partners, in which 
the OR was elevated for same-sex partners, but confidence 
limits included 1.0 (Titus-Ernstoff et al., 2003). In one earlier 
report on prenatal DES exposure, exposed men were less 
likely than unexposed men to be married or living as married 
(Beral & Colwell, 1981), while two larger studies, including 
an analysis of 494 men in the Dieckmann randomized trial 
cohort, found no significant association between DES and 
ever having been married (Vessey, Fairweather, Norman-
Smith, & Buckley, 1983; Wilcox, Baird, Weinberg, Hornsby, 
& Herbst, 1995). Taken together, our findings for the relation 
between prenatal DES exposure and sexual orientation iden-
tity in women and men are consistent with DES not acting as 
a masculinizing agent.
There were too few women or men reporting a gender 
identity different from that assigned at birth to analyze poten-
tial effects of prenatal DES exposure, but this suggests that 
any effect would be small.
Although nondifferential misclassification from under-
reporting of nonheterosexuality stemming from social stig-
matization of homosexuality cannot be ruled out, it seems 
unlikely. The proportion of women and men reporting being 
LGBT (“Do you, personally, identify as lesbian, gay, bisexual 
or transgender?”) in a recent large Gallop poll (Newport, 
2018) conducted in a random sample of Americans born from 
1946 to 1964, approximately the birth cohort in our study, 
was lower (2.4%) than in our study (3.3% overall). Further-
more, the percentage of participants who did not respond or 
indicated they preferred not to respond was very low.
A limitation of our study was the restriction of the analy-
sis to those who answered the 2016 questionnaire. Whether 
participant loss over the 30 years of follow-up was related to 
both sexual orientation/gender identity and DES exposure 
status is unknown. However, an association, whether posi-
tive or inverse, would be exaggerated only if participant loss 
to follow-up was also related to DES exposure status. It is 
also possible that reporting of sexual orientation and gender 
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identity among the DES exposed was influenced by our previ-
ous publication indicating effects in women (Titus-Ernstoff, 
et al., 2003), but this seems unlikely, as concordance between 
1994 and 2016 responses to the sexual orientation questions 
was extremely high. In addition, human sexuality is mark-
edly complex, and our data addressed only one biological 
mechanism regarding exposure to exogenous hormones. As 
complicated as the etiology of sexual orientation is, the etiol-
ogy of gender identity is even more elusive.
The rough approximation of sexual orientation and gender 
identity in our study may have limited our ability to capture 
the constructs being measured and thoroughly examine these 
characteristics with regard to DES exposure. Any random 
misclassification could have resulted in biasing our findings 
to the null. Although possible, it seems unlikely that our 
measures resulted in selectively underestimating the preva-
lence of nonheterosexual orientation in the DES-exposed 
women only. Although our study was large and has docu-
mented DES exposure status, it has limited power to assess 
associations with rare outcomes such as transgender identity. 
Despite limitations, these are unique data on a group of indi-
viduals exposed to high doses of synthetic estrogen during a 
particularly important development period.
In summary, the findings showed that women who were 
prenatally exposed to DES were significantly less likely 
to report being lesbian or bisexual. In contrast, while men 
who were prenatally exposed to DES were somewhat more 
likely to report being gay or bisexual, the estimate was very 
imprecise and compatible with chance. Finally, very few 
individuals reported currently thinking of themselves as 
a gender different from that assigned at birth in either the 
exposed or unexposed group.
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